AdvanSource Biomaterials Corporation - Financial Analysis Review

AdvanSource Biomaterials Corporation - Financial Analysis Review

Summary

AdvanSource Biomaterials Corporation (AdvanSource), formerly known as CardioTech International, Inc., is engaged in developing polymer based materials for the medical and pharmaceutical industries. Its innovative biomaterials can be used as structural engineering polymers or as coatings for a variety of material substrates. In May 2008, CardioTech International formed AdvanSource Biomaterials Corporation as a wholly owned subsidiary. In October 2008, CardioTech International converted itself as AdvanSource Biomaterials Corporation. Currently, its CardioPass is in a clinical trial to obtain CE Mark approval for use in Europe. The company is headquartered in Massachusetts, the US.

Global Markets Direct’s "AdvanSource Biomaterials Corporation - Financial Analysis Review” is an in-depth business and financial analysis of AdvanSource Biomaterials Corporation. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the financial analysis of the company. This highlights the company’s ratio analysis for the past five years.

And More inside the report…

Recent Developments

Nov 12, 2009: AdvanSource Reports Q2 Fiscal 2010 Results
Nov 10, 2009: AdvanSource Signs Supply Agreement With Orthopedic Devices Manufacturer
Aug 19, 2009: AdvanSource Biomaterials Enters Into Multi-year Development Agreement

Scope

- Provides key company information for business intelligence needs
- The report contains critical company information – business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
- The report provides detailed financial ratios for the past five years as well as interim ratios for the last fourinterim periods.
- Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

- A quick “one-stop-shop” to understand the company.
- Enhance business/sales activities by understanding customers’ businesses better.
- Get detailed information and financial analysis on companies operating in your industry.
- Identify prospective partners and suppliers – with key data on their businesses and locations.
- Compare your company’s financial trends with those of your peers / competitors.
- Scout for potential acquisition targets, with insight into the companies’ financial performance.

Report Highlights

The following companies are the major competitors of AdvanSource Biomaterials Corporation:
Possis Medical, Inc.
Stryker Corporation
Terumo Corporation
[Studien Infos ausblenden]

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
AdvanSource Biomaterials Corporation - Key Facts 4
AdvanSource Biomaterials Corporation - Business Description 4
AdvanSource Biomaterials Corporation - Major Products and Services 5
AdvanSource Biomaterials Corporation - History 6
AdvanSource Biomaterials Corporation - Key Competitors 7
AdvanSource Biomaterials Corporation - Key Employees 7
AdvanSource Biomaterials Corporation - Key Employee Biographies 7
AdvanSource Biomaterials Corporation - Company Statement 8
AdvanSource Biomaterials Corporation - Locations And Subsidiaries 9
Head Office 9
AdvanSource Biomaterials Corporation - Financial Ratios 10
Financial Ratios - Capital Market Ratios 10
Financial Ratios - Annual Ratios 10
Financial Ratios - Interim Ratios 11
Financial Ratios - Ratio Charts 12
Recent Developments 13
Corporate Communications 13
Mar 04, 2009: AdvanSource CFO Resigns 13
Feb 12, 2008: CardioTech Appoints Global Sales Director, Materials Science 13
Legal and Regulatory 13
Aug 12, 2009: AdvanSource Signs Settlement Agreement With MEDOS 13
Product News 14
Jul 11, 2008: CardioTech International Receives FDA Approval For Export Of Second Graft Size For CardioPass Clinical Trial 14
Apr 02, 2008: CardioTech Announces Second Site For CardioPass Clinical Trial 14
Nov 15, 2007: Cardiotech Announces Third Cardiopass Patient And Start Of Phase II Brazilian Clinical Trials 14
Mar 22, 2007: Cardiotech Reports First Surgical Implant Of Cardiopass; Patient Has Been Discharged From Hospital 14
Aug 11, 2006: CardioTech Signs Agreement With Principle Investigator For CardioPass European Clinical Trial 15
Apr 13, 2005: CardioTech Presents Brazilians Living with CardioPass Graft 15
Product Approvals 15
Jul 11, 2008: CardioTech International Receives FDA Approval For Export Of Second Graft Size For CardioPass Clinical Trial 15
Clinical Trials 15
Apr 02, 2008: CardioTech Announces Second Site For CardioPass Clinical Trial 15
Nov 15, 2007: Cardiotech Announces Third Cardiopass Patient And Start Of Phase II Brazilian Clinical Trials 16
Mar 22, 2007: Cardiotech Reports First Surgical Implant Of Cardiopass; Patient Has Been Discharged From Hospital 16
Aug 11, 2006: CardioTech Signs Agreement With Principle Investigator For CardioPass European Clinical Trial 16
Financial Announcements 17
Feb 18, 2009: AdvanSource Reports Q3 Fiscal 2009 Results 17
Aug 13, 2009: AdvanSource Reports Net Revenues Of $450,000 In Q1 Fiscal 2010 17
Nov 12, 2009: AdvanSource Reports Q2 Fiscal 2010 Results 18
Jun 30, 2009: AdvanSource Reports Revenues Of $3.3 Million In Fiscal 2009 20
Feb 12, 2008: CardioTech Reports Q3 Fiscal 2008 Results 21
Aug 13, 2007: CardioTech Reports Q1 Fiscal 2008 Results 22
Jun 27, 2007: CardioTech Reports Q4 Fiscal 2007 Results 23
Feb 15, 2007: CardioTech Reports Q3 Fiscal 2007 Results 23
Jun 25, 2008: CardioTech Reports Q4 Fiscal 2008 Results 24
Aug 13, 2008: CardioTech Reports 1Q Fiscal 2009 Results 25
Nov 13, 2007: CardioTech Reports Q2 Fiscal 2008 Results 26
Other Significant Developments 26
Aug 19, 2009: AdvanSource Biomaterials Enters Into Multi-year Development Agreement 26
Nov 10, 2009: AdvanSource Signs Supply Agreement With Orthopedic Devices Manufacturer 27
Strategy and Business Planning 27
May 30, 2008: CardioTech Launches New Subsidiary 27
Appendix 28
Methodology 28
Ratio Definitions 28
About Global Markets Direct 31
Contact Us 31
Disclaimer 31
[Inhaltsverzeichnis ausblenden]

List of Tables
AdvanSource Biomaterials Corporation, Key Facts 4
AdvanSource Biomaterials Corporation, Major Products and Services 5
AdvanSource Biomaterials Corporation, History 6
AdvanSource Biomaterials Corporation, Key Employees 7
AdvanSource Biomaterials Corporation, Key Employee Biographies 7

List of Figures
AdvanSource Biomaterials Corporation, Performance Chart (2005 - 2009) 1
AdvanSource Biomaterials Corporation, Ratio Charts 12
[Tabellenverzeichnis ausblenden]